Our president, Jennifer Bittinger, joins the CDISC Board of Directors
Our president, Jennifer Bittinger, joins the CDISC Board of Directors
By Sofía Sánchez González
We are pleased to announce that our president, Jennifer Bittinger, has been appointed to the CDISC Board of Directors for a three-year term.
The role of CDISC in clinical research
CDISC (Clinical Data Interchange Standards Consortium) is a global organization that creates common data standards for clinical research. These standards help ensure that clinical trial data can be shared, understood, and analyzed consistently across companies, researchers, and regulatory authorities worldwide.
For example, when a pharmaceutical company submits clinical trial data to a regulator, CDISC standards ensure the data is structured in a way that can be easily reviewed and compared, reducing errors and delays.
At Narrativa, we adhere to CDISC standards as part of our commitment to responsible data management. In an industry where data is highly sensitive, especially patient and research data, trusted standards are essential to ensure information can be used safely and correctly.
That is why we are proud to be part of CDISC. Data quality has been and will continue to be paramount to our success.
New CDISC board members bring deep industry expertise
Jennifer joins an outstanding group of industry leaders, including:
- Yuki Ando (Pharmaceuticals and Medical Devices Agency, PMDA)
- Scott Chetham (Faro Health)
- Patti Compton (Pfizer)
- Ron Fitzmartin (Decision Analytics, LLC)
- Bill Illis (Novartis)
Together, they bring deep expertise in clinical data science, innovation, and executive leadership, strengthening CDISC’s ability to advance global data standards across the clinical research lifecycle.
CDISC board responsibilities
Members of the CDISC Board of Directors serve three-year terms and play a key role in advancing the organization’s mission to improve the use of data in clinical research worldwide.
We congratulate Jennifer on this well-deserved appointment and are proud to see her contribute her leadership and vision to an organization that plays a critical role in the global clinical research ecosystem.
“Clinical research has a direct impact on people’s lives. Supporting CDISC’s work on global data standards is both a responsibility and a privilege, and I am grateful to contribute alongside such an experienced group of leaders.”
Jennifer Bittinger, President of Narrativa
About Narrativa
Narrativa® is the global leader in generative AI content automation. Through the no-code Narrativa® Navigator platform and the collaborative writing assistant, Narrativa® Sidekick, organizations large and small are empowered to accelerate content creation at scale with greater speed, accuracy, and efficiency.
For companies in the life sciences industry, Narrativa® Navigator provides secure and specialized AI-powered automation features. It includes complementary user-friendly tools such as Clinical Atlas, Narrative Pathway, R-Developer for TLFs, and Redaction Scout, which operate cohesively to transform clinical data into submission-ready regulatory documents. From database to delivery, pharmaceutical sponsors, biotech firms, and contract research organizations (CROs) rely on Narrativa® to streamline workflows, decrease costs, and reduce time-to-market across the clinical lifecycle and, more broadly, throughout their entire businesses.
The dynamic Narrativa® Navigator platform also supports non-clinical industries such as finance, marketing, and media. It helps teams drive measurable impact by creating high-quality, scalable content on any topic. Available as a self-serve SaaS solution or a fully managed service, built-in AI agents enable the production, refinement, and iteration of large volumes of SEO-optimized news articles, engaging blog posts, insightful thought leadership pieces, in-depth financial reports, dynamic social media posts, compelling white papers, and much more.
Explore www.narrativa.com and follow on LinkedIn, Facebook, Instagram, and X. Accelerate the potential with Narrativa®.